Three steps toward dose optimization for oncology dose finding

Background: Traditional dose selection for oncology registration trials typically employs a one- or two-step single maximum tolerated dose (MTD) approach. However, this approach may not be appropriate for molecularly targeted therapy, which tends to have toxicity profiles that are markedly different...

Full description

Bibliographic Details
Published in:Contemporary Clinical Trials Communications
Main Authors: Jason J.Z. Liao, Ekaterine Asatiani, Qingyang Liu, Kevin Hou
Format: Article
Language:English
Published: Elsevier 2024-08-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865424000760